HRMY - Harmony Biosciences Holdings, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Harmony Biosciences Holdings, Inc.
IPO Date: August 19, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $2.29B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.86 | 2.35%
Avg Daily Range (30 D): $0.68 | 1.65%
Avg Daily Range (90 D): $0.73 | 1.97%
Institutional Daily Volume
Avg Daily Volume: .46M
Avg Daily Volume (30 D): .7M
Avg Daily Volume (90 D): .64M
Trade Size
Avg Trade Size (Sh.): 52
Avg Trade Size (Sh.) (30 D): 53
Avg Trade Size (Sh.) (90 D): 52
Institutional Trades
Total Institutional Trades: 2,417
Avg Institutional Trade: $2.49M
Avg Institutional Trade (30 D): $3.8M
Avg Institutional Trade (90 D): $3.74M
Avg Institutional Trade Volume: .07M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.25M
Avg Closing Trade (30 D): $7.56M
Avg Closing Trade (90 D): $6.49M
Avg Closing Volume: 91.01K
 
News
Oct 6, 2026 @ 2:40 PM
HRMY vs. CSLLY: Which Stock Is the Better Value Op...
Source: Na
Oct 6, 2026 @ 12:40 PM
Is Harmony Biosciences (HRMY) Stock Undervalued Ri...
Source: Na
May 19, 2026 @ 9:33 PM
A beaten-down biotech just lost a meaningful backe...
Source: Seena Hassouna
Apr 16, 2026 @ 5:21 PM
12 Small-Cap Stocks Primed for Breakouts as Earnin...
Source: David Wagner
Feb 1, 2026 @ 3:19 AM
Harmony Biosciences' CFO Sells All of Her Insider ...
Source: Adé Hennis
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $3.14 $1.3 $.56
Diluted EPS $3.09 $1.28 $.55
Revenue $959.9M $261.28M $215.39M
Gross Profit $723.99M $198.08M $170.88M
Net Income / Loss $181.27M $75.43M $32.49M
Operating Income / Loss $230.65M $89.32M $37.29M
Cost of Revenue $235.91M $63.2M $44.51M
Net Cash Flow $3.72M $-39.63M $-163.1M
PE Ratio